FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2051497763> ?p ?o ?g. }

• W2051497763 abstract "Abstract Background Data on utilization patterns and safety of non-steroidal anti-inflammatory drugs (NSAIDs) in children are scarce. The purpose of this study was to investigate the utilization of NSAIDs among children in four European countries as part of the Safety Of non-Steroidal anti-inflammatory drugs (SOS) project. Methods We used longitudinal patient data from seven databases (GePaRD, IPCI, OSSIFF, Pedianet, PHARMO, SISR, and THIN) to calculate prevalence rates of NSAID use among children (0–18 years of age) from Germany, Italy, Netherlands, and United Kingdom. All databases contained a representative population sample and recorded demographics, diagnoses, and drug prescriptions. Prevalence rates of NSAID use were stratified by age, sex, and calendar time. The person-time of NSAID exposure was calculated by using the duration of the prescription supply. We calculated incidence rates for serious adverse events of interest. For these adverse events of interest, sample size calculations were conducted (alpha = 0.05; 1-beta = 0.8) to determine the amount of NSAID exposure time that would be required for safety studies in children. Results The source population comprised 7.7 million children with a total of 29.6 million person-years of observation. Of those, 1.3 million children were exposed to at least one of 45 NSAIDs during observation time. Overall prevalence rates of NSAID use in children differed across countries, ranging from 4.4 (Italy) to 197 (Germany) per 1000 person-years in 2007. For Germany, United Kingdom, and Italian pediatricians, we observed high rates of NSAID use among children aged one to four years. For all four countries, NSAID use increased with older age categories for children older than 11. In this analysis, only for ibuprofen (the most frequently used NSAID), enough exposure was available to detect a weak association (relative risk of 2) between exposure and asthma exacerbation (the most common serious adverse event of interest). Conclusions Patterns of NSAID use in children were heterogeneous across four European countries. The SOS project platform captures data on more than 1.3 million children who were exposed to NSAIDs. Even larger data platforms and the use of advanced versions of case-only study designs may be needed to conclusively assess the safety of these drugs in children." @default.
• W2051497763 created "2016-06-24" @default.
• W2051497763 creator A5002490041 @default.
• W2051497763 creator A5011711127 @default.
• W2051497763 creator A5017398074 @default.
• W2051497763 creator A5020080817 @default.
• W2051497763 creator A5020118294 @default.
• W2051497763 creator A5031396246 @default.
• W2051497763 creator A5032192131 @default.
• W2051497763 creator A5043350936 @default.
• W2051497763 creator A5057157459 @default.
• W2051497763 creator A5061279178 @default.
• W2051497763 creator A5070504206 @default.
• W2051497763 creator A5071030647 @default.
• W2051497763 creator A5077586396 @default.
• W2051497763 creator A5081503066 @default.
• W2051497763 creator A5082450368 @default.
• W2051497763 date "2013-11-19" @default.
• W2051497763 modified "2023-10-18" @default.
• W2051497763 title "Population-based analysis of non-steroidal anti-inflammatory drug use among children in four European countries in the SOS project: what size of data platforms and which study designs do we need to assess safety issues?" @default.
• W2051497763 cites W1561057973 @default.
• W2051497763 cites W1960737837 @default.
• W2051497763 cites W1969511755 @default.
• W2051497763 cites W1973734933 @default.
• W2051497763 cites W1991473061 @default.
• W2051497763 cites W1991996972 @default.
• W2051497763 cites W2001426216 @default.
• W2051497763 cites W2006010099 @default.
• W2051497763 cites W2022569477 @default.
• W2051497763 cites W2035164500 @default.
• W2051497763 cites W2050145647 @default.
• W2051497763 cites W2099607051 @default.
• W2051497763 cites W2109584152 @default.
• W2051497763 cites W2110427128 @default.
• W2051497763 cites W2118878320 @default.
• W2051497763 cites W2136527705 @default.
• W2051497763 cites W2138421921 @default.
• W2051497763 cites W2147291501 @default.
• W2051497763 cites W2148303708 @default.
• W2051497763 cites W2149253174 @default.
• W2051497763 cites W2154272279 @default.
• W2051497763 cites W2156662512 @default.
• W2051497763 cites W2164171458 @default.
• W2051497763 cites W2164595809 @default.
• W2051497763 cites W2326455719 @default.
• W2051497763 cites W4235807208 @default.
• W2051497763 doi "https://doi.org/10.1186/1471-2431-13-192" @default.
• W2051497763 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4225575" @default.
• W2051497763 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24252465" @default.
• W2051497763 hasPublicationYear "2013" @default.
• W2051497763 type Work @default.
• W2051497763 sameAs 2051497763 @default.
• W2051497763 citedByCount "37" @default.
• W2051497763 countsByYear W20514977632015 @default.
• W2051497763 countsByYear W20514977632016 @default.
• W2051497763 countsByYear W20514977632017 @default.
• W2051497763 countsByYear W20514977632018 @default.
• W2051497763 countsByYear W20514977632019 @default.
• W2051497763 countsByYear W20514977632020 @default.
• W2051497763 countsByYear W20514977632021 @default.
• W2051497763 countsByYear W20514977632022 @default.
• W2051497763 countsByYear W20514977632023 @default.
• W2051497763 crossrefType "journal-article" @default.
• W2051497763 hasAuthorship W2051497763A5002490041 @default.
• W2051497763 hasAuthorship W2051497763A5011711127 @default.
• W2051497763 hasAuthorship W2051497763A5017398074 @default.
• W2051497763 hasAuthorship W2051497763A5020080817 @default.
• W2051497763 hasAuthorship W2051497763A5020118294 @default.
• W2051497763 hasAuthorship W2051497763A5031396246 @default.
• W2051497763 hasAuthorship W2051497763A5032192131 @default.
• W2051497763 hasAuthorship W2051497763A5043350936 @default.
• W2051497763 hasAuthorship W2051497763A5057157459 @default.
• W2051497763 hasAuthorship W2051497763A5061279178 @default.
• W2051497763 hasAuthorship W2051497763A5070504206 @default.
• W2051497763 hasAuthorship W2051497763A5071030647 @default.
• W2051497763 hasAuthorship W2051497763A5077586396 @default.
• W2051497763 hasAuthorship W2051497763A5081503066 @default.
• W2051497763 hasAuthorship W2051497763A5082450368 @default.
• W2051497763 hasBestOaLocation W20514977631 @default.
• W2051497763 hasConcept C120665830 @default.
• W2051497763 hasConcept C121332964 @default.
• W2051497763 hasConcept C126322002 @default.
• W2051497763 hasConcept C144024400 @default.
• W2051497763 hasConcept C149923435 @default.
• W2051497763 hasConcept C187212893 @default.
• W2051497763 hasConcept C197934379 @default.
• W2051497763 hasConcept C23276603 @default.
• W2051497763 hasConcept C2426938 @default.
• W2051497763 hasConcept C2908647359 @default.
• W2051497763 hasConcept C61511704 @default.
• W2051497763 hasConcept C71924100 @default.
• W2051497763 hasConcept C98274493 @default.
• W2051497763 hasConcept C99454951 @default.
• W2051497763 hasConceptScore W2051497763C120665830 @default.
• W2051497763 hasConceptScore W2051497763C121332964 @default.
• W2051497763 hasConceptScore W2051497763C126322002 @default.
• W2051497763 hasConceptScore W2051497763C144024400 @default.
• W2051497763 hasConceptScore W2051497763C149923435 @default.
• W2051497763 hasConceptScore W2051497763C187212893 @default.
• W2051497763 hasConceptScore W2051497763C197934379 @default.

• next